Oversubscribed £2.5M seed round led by Ahren Innovation Capital Strategic collaboration with o2h to progress drug discovery programme OutSee, a genomics and drug discovery company pioneering a unique ...
A Cambridge-based firm which applies AI predictive genomics to drug target discovery has completed a £2.5m seed funding round and signed a new partnership. The round for OutSee was led by Ahren ...
CAMBRIDGE, England, January 12, 2026--(BUSINESS WIRE)--OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the ...
OutSee, a genomics and drug discovery company pioneering a unique AI-based predictive genomics approach to target discovery, today announced the closure of its £2.5 M seed funding round. The Company ...
Oversubscribed £2.5M seed round led by Ahren Innovation Capital Strategic collaboration with o2h to progress drug discovery programme CAMBRIDGE, England--(BUSINESS WIRE)--OutSee, a genomics and drug ...
Welcome back to Changing Faces, in our final round-up for August and September there are plenty of Board appointments to report on, including a lot of impressive Scientific Advisory Boards. Read on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback